Jon D Levine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Paul Green

Professor

University of California, San Francisco

UNITED STATES

View details

Samantha J. Mayo

Associate Professor

University of Toronto

CANADA

View details

Kord Kober

Associate Professor

University of California, San Francisco

UNITED STATES

View details

Joosun Shin

University of California, Los Angeles

UNITED STATES

View details

Yvette P. Conley

University of Pittsburgh

UNITED STATES

View details

Yufen Lin

Assistant Professor

Emory University

UNITED STATES

View details

Joaquin A. Anguera

Associate Professor

University of California, San Francisco

UNITED STATES

View details

Christine Miaskowski

University of California

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jon D Levine

Research Interests

Explore related searches

Contact this professor

Articles (24)

Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways

Lower Functional Status, Higher Comorbidity Burden, and Higher Levels of Stress Are Associated With Worse Joint Evening Fatigue and Depressive Symptom Profiles in Outpatients Receiving Chemotherapy

G-protein–coupled estrogen receptor 30 regulation of signaling downstream of protein kinase Cε mediates sex dimorphism in hyaluronan-induced antihyperalgesia

Neurodegenerative disease pathways are perturbed in patients with cancer who self‐report cognitive changes and anxiety: A pathway impact analysis

A novel anti-pruritic: Topical co-administration of high molecular weight hyaluronan (HMWH) with protamine, a transdermal transport enhancer

Isolectin B4 (IB4)-conjugated streptavidin for the selective knockdown of proteins in IB4-positive (+) nociceptors

Morphine acts in vitro to directly prime nociceptors

Sensitization of human and rat nociceptors by low dose morphine is toll-like receptor 4-dependent

Chemotherapy for pain: reversing inflammatory and neuropathic pain with the anticancer agent mithramycin A

Common and distinct risk factors that influence more severe and distressing shortness of breath profiles in oncology outpatients

Distinct Co-occurring Morning and Evening Fatigue Profiles in Patients with Gastrointestinal Cancers Receiving Chemotherapy

Exploration of the Relationships between Stress and Distinct Pain and Sleep Disturbance Profiles in Patients Undergoing Chemotherapy

Mu-Opioid Receptor (MOR) Dependence of Pain in Chemotherapy-Induced Peripheral Neuropathy

Prediction of morning fatigue severity in outpatients receiving chemotherapy: less may still be more

Perturbations in common and distinct inflammatory pathways associated with morning and evening fatigue in outpatients receiving chemotherapy

Neuroendocrine mechanisms in oxaliplatin-induced hyperalgesic priming

Role of pattern recognition receptors in chemotherapy-induced neuropathic pain

Topical coapplication of hyaluronan with transdermal drug delivery enhancers attenuates inflammatory and neuropathic pain

Second messengers mediating high-molecular-weight hyaluronan–induced antihyperalgesia in rats with chemotherapy-induced peripheral neuropathy

Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy

Contribution of G-Protein α-Subunits to Analgesia, Hyperalgesia, and Hyperalgesic Priming Induced by Subanalgesic and Analgesic Doses of Fentanyl and Morphine

PI3Kγ/AKT Signaling in High Molecular Weight Hyaluronan (HMWH)-Induced Anti-Hyperalgesia and Reversal of Nociceptor Sensitization

Opioid-Induced Hyperalgesic Priming in Single Nociceptors

Mechanisms Mediating High-Molecular-Weight Hyaluronan-Induced Antihyperalgesia

Collaborators (8)

Paul Green

Samantha J. Mayo

Kord Kober

Joosun Shin

Yvette P. Conley

Yufen Lin

Joaquin A. Anguera

Christine Miaskowski

Make your next move.